Rerouting phytosterol degradation pathway for directed androst-1,4-diene-3,17-dione microbial bioconversion
Authors:
Open Access
- 1 February 2024
- journal article
- research article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 108 (1) , 1-12
Abstract
Steroid-based drugs are now mainly produced by the microbial transformation of phytosterol, and a two-step bioprocess is adopted to reach high space–time yields, but byproducts are frequently observed during the bioprocessing. In this study, the catabolic switch between the C19- and C22-steroidal subpathways was investigated in resting cells of Mycobacterium neoaurum NRRL B-3805, and a dose-dependent transcriptional response toward the induction of phytosterol with increased concentrations was found in the putative node enzymes including ChoM2, KstD1, OpccR, Sal, and Hsd4A. Aldolase Sal presented a dominant role in the C22 steroidal side-chain cleavage, and the byproduct was eliminated after sequential deletion of opccR and sal. Meanwhile, the molar yield of androst-1,4-diene-3,17-dione (ADD) was increased from 59.4 to 71.3%. With the regard of insufficient activity of rate-limiting enzymes may also cause byproduct accumulation, a chromosomal integration platform for target gene overexpression was established supported by a strong promoter L2 combined with site-specific recombination in the engineered cell. Rate-limiting steps of ADD bioconversion were further characterized and overcome. Overexpression of the kstD1 gene further strengthened the bioconversion from AD to ADD. After subsequential optimization of the bioconversion system, the directed biotransformation route was developed and allowed up to 82.0% molar yield with a space–time yield of 4.22 g·L−1·day−1. The catabolic diversion elements and the genetic overexpression tools as confirmed and developed in present study offer new ideas of M. neoaurum cell factory development for directed biotransformation for C19- and C22-steroidal drug intermediates from phytosterol. Key points: • Resting cells exhibited a catabolic switch between the C19- and C22-steroidal subpathways. • The C22-steroidal byproduct was eliminated after sequential deletion of opccR and sal. • Rate-limiting steps were overcome by promoter engineering and chromosomal integration.Keywords
Funding Information
- Program of the National key Research and Development Program of China (2019YFA0905300)
- Natural Science Foundation of Zhejiang Province (LY23C010004)
This publication has 43 references indexed in Scilit:
- FadA5 a Thiolase from Mycobacterium tuberculosis: A Steroid-Binding Pocket Reveals the Potential for Drug Development against TuberculosisStructure, 2015
- Characterization and engineering of 3-ketosteroid-△1-dehydrogenase and 3-ketosteroid-9α-hydroxylase in Mycobacterium neoaurum ATCC 25795 to produce 9α-hydroxy-4-androstene-3,17-dione through the catabolism of sterolsMetabolic Engineering, 2014
- Crystal Structure and Site-directed Mutagenesis of 3-Ketosteroid Δ1-Dehydrogenase from Rhodococcus erythropolis SQ1 Explain Its Catalytic MechanismJournal of Biological Chemistry, 2013
- The Essential Function of Genes for a Hydratase and an Aldehyde Dehydrogenase for Growth of Pseudomonas sp. Strain Chol1 with the Steroid Compound Cholate Indicates an Aldolytic Reaction Step for Deacetylation of the Side ChainJournal of Bacteriology, 2013
- A comparative analysis of the properties of regulated promoter systems commonly used for recombinant gene expression in Escherichia coliMicrobial Cell Factories, 2013
- Identification and engineering of cholesterol oxidases involved in the initial step of sterols catabolism in Mycobacterium neoaurumMetabolic Engineering, 2013
- Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2Microbiology, 2010
- Steroid-1-dehydrogenase of Mycobacterium sp. VKM Ac-1817D strain producing 9α-hydroxy-androst-4-ene-3,17-dione from sitosterolApplied Microbiology and Biotechnology, 2007
- Mycobacterium sp. mutant strain producing 9α-hydroxyandrostenedione from sitosterolApplied Microbiology and Biotechnology, 2005
- Method to integrate multiple plasmids into the mycobacterial chromosomeNucleic Acids Research, 2004